<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine incidence and type of major cardiac adverse events in patients with mutated desmin (DES) gene, we retrospectively reviewed baseline medical information, and examined the long-term outcomes of 28 DES patients (17 men, baseline mean age=37.7±14.4 years [min=9, max=71]) from 19 families </plain></SENT>
<SENT sid="1" pm="."><plain>Baseline studies revealed skeletal muscle involvement in 21 patients and <z:hpo ids='HP_0001627'>cardiac abnormalities</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> but one patient </plain></SENT>
<SENT sid="2" pm="."><plain>Over a mean follow-up of 10.4±9.4 years [min=1, max=35], cardiac <z:hpo ids='HP_0011420'>death</z:hpo> occurred in three patients, <z:hpo ids='HP_0011420'>death</z:hpo> due to cardiac comorbidities in two, one or more major cardiac adverse events in 13 patients </plain></SENT>
<SENT sid="3" pm="."><plain>Among the 19 patients with mild <z:e sem="disease" ids="C0264886" disease_type="Disease or Syndrome" abbrv="">conduction defects</z:e> at baseline, eight developed high-degree conduction blocks requiring permanent pacing </plain></SENT>
<SENT sid="4" pm="."><plain>Cardiac involvement was neither correlated with the type of DES mutation nor with the severity of skeletal muscle involvement </plain></SENT>
<SENT sid="5" pm="."><plain>Our study underscores that in DES patients in-depth cardiac investigations are needed to prevent cardiac conduction system disease </plain></SENT>
</text></document>